Demonstration of neuroprotective effects of Nrf2 activators DMF and MMF against MPTP neurotoxicity in wild-type but not Nrf2 null mice revealed the importance of Nrf2 pathway in PD pathogenesis, and stimulation of this pathway may be a therapeutic approach for PD (177). This evidence concerns the gene NFE2L2 and Parkinson disease.